Effectiveness of Non-invasive Phrenic Nerve Neuromodulation in Subjects With Inflammatory Bowel Disease and Neck Pain.

NACompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

January 30, 2024

Primary Completion Date

November 15, 2024

Study Completion Date

February 17, 2025

Conditions
Inflammatory Bowel DiseasesNeck Pain
Interventions
DEVICE

Non-invasive Neuromodulation

"This intervention group will receive neuromodulation treatment two days a week for a total of six sessions.~The patient is placed in the supine position with a cushion under the knees. The physiotherapist will be positioned behind the patient's head on the side to be treated. The technique will be applied on both anterolateral sides of the neck, where the Phrenic nerve passes in front of the anterior Scalene, between the Subclavian arteries and veins. Neuromodulation will be applied with a Pointer Excel II. It will be applied with negative polarity, at a frequency of 2 Hertz (HZ) and with a current intensity varying between 0 and 45 milliamperes (mA). The intensity shall be increased progressively until the patient's diaphragmatic contraction can be observed without pain. The technique shall be applied on each side for a total of 8 minutes, divided into intervals of 10 seconds of stimulation and 20 seconds of rest."

OTHER

Cervico-dorsal Massage

"This intervention group will receive manual therapy two days a week for a total of six sessions.~The patient shall be placed prone position with a cushion under his or her feet. This group will receive manual therapy on the entire posterior cervical and dorsal region, the area between the occipital bone, the shoulders and the scapulae. The massage will be carried out with a little oil or cream for about 20 minutes."

Trial Locations (1)

11510

Hospital Universitario Puerto Real, Puerto Real

All Listed Sponsors
lead

University of Seville

OTHER

NCT06288061 - Effectiveness of Non-invasive Phrenic Nerve Neuromodulation in Subjects With Inflammatory Bowel Disease and Neck Pain. | Biotech Hunter | Biotech Hunter